Ισραήλ - Εβραϊκά - Ministry of Health

אינטרומדיקס בע"מ - רופא - כירורגית כללית

Ισραήλ - Εβραϊκά - Ministry of Health

sion biotext medical - רופא - מיועד לשימוש נרחב בכל המחלקות בהם יש פצעים חבושים, פלסטרים דבוקים לעור, כרורגיה פצעי ניתוחים, סטומות למינהן, מחלקות נפרולוגיה, פגיות, גריאטריה, אונקולוגיה

Ισραήλ - Εβραϊκά - Ministry of Health

slp ltd. - אחר - ורפואת שינה eeg

Ισραήλ - Εβραϊκά - Ministry of Health

דין דיאגנוסטיקה בע"מ - כלל האוכלוסיה - הקלה וטיפול בעור בכף רגל סוכרתית

Ισραήλ - Εβραϊκά - Ministry of Health

taro international ltd, israel - abacavir; lamivudine - טבליות מצופות פילם - lamivudine 300 mg; abacavir 600 mg - lamivudine and abacavir

Ισραήλ - Εβραϊκά - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - erlotinib hydrochloride - טבליות מצופות פילם - erlotinib hydrochloride 100 mg - erlotinib

Ισραήλ - Εβραϊκά - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - erlotinib as hydrochloride - טבליות מצופות פילם - erlotinib as hydrochloride 150 mg - erlotinib

Ισραήλ - Εβραϊκά - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - erlotinib hydrochloride - טבליות מצופות פילם - erlotinib hydrochloride 25 mg - erlotinib

Ισραήλ - Εβραϊκά - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

Ισραήλ - Εβραϊκά - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 2000 iu / 1 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob